Tevogen Inc. (TVGNW) stock
TVGNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGN
$0.09+0.01 (+18.24%)
Close on Oct 30, 2026Market cap $38.42MP/E –Yield –
Tevogen free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Tevogen's free cash flow for the twelve months ending Dec 31, 2023 was -$8.30M. For fiscal 2025 it was -$12.39M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$12.39M | – |
| FY2023 | Dec 31, 2023 | -$8.30M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | -$1.98M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.80M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.22M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.31M | – |